Author(s): Ali MK, Narayan KM, Tandon N
Coronary heart disease (CHD) is currently the leading cause of death worldwide and together with diabetes, poses a serious health threat, particularly in the Indian Asian population. Risk factor management has evolved considerably with the continued emergence of new and thought-provoking evidence. The stream of laboratory- and population-based research findings as well as unresolved controversies may pose dilemmas and conflicting impulses in most clinicians, and even in our more well-informed patients. As results of the most recent clinical trials on glycaemic control for macrovascular risk reduction are woven into concrete clinical practice guidelines, this paper seeks to sort through unwieldy evidence, keeping these findings in perspective, to deliver a clearer message for the context of South Asia and cardio-metabolic risk management.
Referred From: https://www.ncbi.nlm.nih.gov/pubmed/21150011
Author(s): Alexander CM, Landsman PB, Teutsch SM
Author(s): Yoo WS, Kim HJ, Kim D, Lee MY, Chung HK
Author(s): Naka M, Hiramatsu K, Aizawa T, Momose A, Yoshizawa K, et al.
Author(s): Chopra S, Peter S
Author(s): Janand-Delenne B, Savin B, Habib G, Bory M, Vague P, et al.
Author(s): Langer A, Freeman MR, Josse RG, Steiner G, Armstrong PW
Author(s): Gazzaruso C, Garzaniti A, Giordanetti S, Falcone C, Fratino P
Author(s): Bacci S, Villella M, Villella A, Langialonga T, Grilli M, et al.
Author(s): Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, et al.
Author(s): Sargin H, Ozisik M, Ozisik NC, Omer S, Orbay E, et al.
Author(s): Foster MC, Hwang SJ, Larson MG, Parikh NI, Meigs JB, et al.
Author(s): Hernández C, Candell-Riera J, Ciudin A, Francisco G, Aguadé-Bruix S, et al.